Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies
Stopped Enrolment period completed and sufficient number of enrolments to achieve study objectives
Conditions
- Cystic Fibrosis
- CFTR Gene Mutation
Interventions
- PROCEDURE: Nasal cells sampling
- PROCEDURE: Rectal biopsy sampling
Sponsor
University Hospital, Montpellier
Collaborators
- [object Object]
- [object Object]
- [object Object]